Constitutional Opinion No. 2026-1004

America First Constitutional Standard — Version 1.0

Case Information

Content Scored: HHS, FDA Commend DEA Action Against Dangerous Enhanced 7-OH Products
Source: U.S. Department of Health and Human Services (HHS Press Office / FDA)
Author: —
Publication Date: July 1, 2026
Content Type: Official Communication
Opinion Issued: 2026-07-30
AFCS Version: 1.0
URL: https://www.hhs.gov/press-room/hhs-fda-support-dea-7-oh-scheduling.html

Holding

The DEA's Notices of Intent to begin temporary Schedule I placement of concentrated 7-OH and its synthetic derivatives advance Article XVIII by acting against a growing threat to public safety through lawful process, Article V by protecting life from deadly and addictive opioids, and Article II by shielding citizens from deceptive dangerous products while inviting public comment through a Request for Information. The measured administrative process, comment period, and prior scientific review support the item's reliability. Tier 1 79, Tier 2 84 under default 70/30 weighting; raw and final score 81, no Automatic Fail. Labeled America First.

Loading Opinion…

Framer Tools

Export this Opinion or copy a formatted citation.

It is the judgment of this Court that Opinion No. 2026-1004 is hereby entered into the record, in accordance with the America First Constitutional Standard. The score stands. The reasoning is published. The record is public.

The Standard is the Standard.

View Original Source